| Year |
Citation |
Score |
| 2022 |
Fasching PA, Liu D, Scully S, Ingle JN, Lyra PC, Rack B, Hein A, Ekici AB, Reis A, Schneeweiss A, Tesch H, Fehm TN, Heinrich G, Beckmann MW, Ruebner M, ... ... Fridley BL, et al. Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Breast Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 35653140 DOI: 10.1158/1078-0432.CCR-20-4774 |
0.305 |
|
| 2022 |
Sasamoto N, Stewart PA, Wang T, Yoder SJ, Chellappan S, Hecht JL, Fridley BL, Terry KL, Tworoger SS. Lifetime ovulatory years and ovarian cancer gene expression profiles. Journal of Ovarian Research. 15: 59. PMID 35562768 DOI: 10.1186/s13048-022-00995-1 |
0.314 |
|
| 2022 |
Buras AL, Wang T, Whiting J, Townsend MK, Fridley BL, Tworoger SS. Prospective Analyses of Sedentary Behavior in Relation to Risk of Ovarian Cancer. American Journal of Epidemiology. PMID 35094053 DOI: 10.1093/aje/kwac018 |
0.304 |
|
| 2020 |
Reid BM, Fridley BL. DNA Methylation in Ovarian Cancer Susceptibility. Cancers. 13. PMID 33396385 DOI: 10.3390/cancers13010108 |
0.315 |
|
| 2020 |
Mills M, Liveringhouse C, Lee F, Nanda RH, Ahmed KA, Washington IR, Thapa R, Fridley BL, Blumencranz P, Extermann M, Loftus L, Balducci L, Diaz R. The prevalence of luminal B subtype is higher in older postmenopausal women with ER+/HER2- breast cancer and is associated with inferior outcomes. Journal of Geriatric Oncology. PMID 32859560 DOI: 10.1016/J.Jgo.2020.08.007 |
0.349 |
|
| 2020 |
Kho PF, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Brinton L, Buchanan DD, Chanock SJ, Chen C, Chen MM, Cheng THT, Cook LS, ... ... Fridley BL, et al. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer. International Journal of Cancer. PMID 32851660 DOI: 10.1002/Ijc.33206 |
0.417 |
|
| 2020 |
Oesterheld JE, Reed DR, Setty BA, Isakoff MS, Thompson P, Yin H, Hayashi M, Loeb DM, Smith T, Makanji R, Fridley BL, Wagner LM. Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer Foundation. Pediatric Blood & Cancer. e28370. PMID 32386107 DOI: 10.1002/Pbc.28370 |
0.341 |
|
| 2020 |
Chalise P, Ni Y, Fridley BL. Network-based integrative clustering of multiple types of genomic data using non-negative matrix factorization. Computers in Biology and Medicine. 118: 103625. PMID 31999549 DOI: 10.1016/J.Compbiomed.2020.103625 |
0.301 |
|
| 2020 |
Sasamoto N, Townsend M, Abbas-Aghababazadeh F, Terry KL, Johnson JO, Hecht JL, Fridley BL, Tworoger SS. Abstract 34: Predictors of discordance between image-based and manual scoring of immunohistochemical stains in ovarian cancer tissue microarrays Epidemiology. DOI: 10.1158/1538-7445.Am2020-34 |
0.337 |
|
| 2020 |
Mitchell R, Howard R, Lewis P, Fellows K, Jones J, Reisman P, Fridley B, Rollison D. Abstract 2101: Deep learning for automatic extraction of tumor site and histology from unstructured pathology reports Cancer Research. 80: 2101-2101. DOI: 10.1158/1538-7445.Am2020-2101 |
0.313 |
|
| 2020 |
Matejcic M, Teer JK, Hoehn HJ, Chen Z, Diaz DB, Nguyen N, Cress D, Carballido E, Fleming J, Coppola D, Stern MC, Fridley BL, Figueiredo JC, Schmit SL. Abstract 1192: Genetic ancestry and somatic mutational frequencies in colorectal cancer: Findings from the Latino Colorectal Cancer Consortium Epidemiology. 80: 1192-1192. DOI: 10.1158/1538-7445.Am2020-1192 |
0.399 |
|
| 2019 |
Peres LC, Sinha S, Townsend MK, Fridley BL, Karlan BY, Lutgendorf SK, Shinn E, Sood AK, Tworoger SS. Predictors of survival trajectories among women with epithelial ovarian cancer. Gynecologic Oncology. PMID 31839342 DOI: 10.1016/J.Ygyno.2019.12.011 |
0.368 |
|
| 2019 |
Mallen AR, Conley CC, Townsend MK, Wells A, Boac BM, Todd S, Gandhi A, Kuznicki M, Augusto BM, McIntyre M, Fridley BL, Tworoger SS, Wenham RM, Vadaparampil ST. Patterns and Predictors of Genetic Referral among Ovarian Cancer Patients at a National Cancer Institute Comprehensive Cancer Center. Clinical Genetics. PMID 31600840 DOI: 10.1111/Cge.13654 |
0.375 |
|
| 2019 |
Abbas-Aghababazadeh F, Lu P, Fridley BL. Nonlinear mixed-effects models for modeling in vitro drug response data to determine problematic cancer cell lines. Scientific Reports. 9: 14421. PMID 31594982 DOI: 10.1038/S41598-019-50936-0 |
0.322 |
|
| 2019 |
Abbas-Aghababazadeh F, Mo Q, Fridley BL. Statistical Genomics in Rare Cancer. Seminars in Cancer Biology. PMID 31437624 DOI: 10.1016/J.Semcancer.2019.08.021 |
0.432 |
|
| 2019 |
Reid BM, Permuth JB, Chen YA, Fridley BL, Iversen ES, Chen Z, Jim H, Vierkant RA, Cunningham JM, Barnholtz-Sloan JS, Narod S, Risch H, Schildkraut JM, Goode EL, Monteiro AN, et al. Genome-wide analysis of common copy number variation and epithelial ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30948450 DOI: 10.1158/1055-9965.Epi-18-0833 |
0.447 |
|
| 2019 |
Han H, Khong H, Costa R, Loftus L, Goodridge D, Henry T, Soliman H, Ismail-Khan R, Fridley B, Czerniecki B. Abstract P2-09-15: A phase I study of interferon-gamma (γ)plus weekly paclitaxel, trastuzumab and pertuzumab in patients with HER-2 positive breast cancer Cancer Research. 79. DOI: 10.1158/1538-7445.Sabcs18-P2-09-15 |
0.319 |
|
| 2019 |
Mallen A, Townsend M, Boac B, Todd S, Gandhi A, Kuznicki M, Magliocco A, Fridley B, Tworoger S, Vadaparampil S, Wenham R. Predictive factors of genetic referral for advanced, epithelial ovarian cancer patients at a Single-Institution Cancer Center Gynecologic Oncology. 154: e14-e15. DOI: 10.1016/J.Ygyno.2019.03.191 |
0.412 |
|
| 2019 |
Gandhi A, Kuznicki M, Mallen A, Todd S, Boac B, Cao B, Magliocco A, Fridley B, Wenham R, Chon H. Comparison of treatment and outcomes between medical oncology and gynecologic oncology as adjuvant chemotherapy provider in an advanced ovarian cancer population Gynecologic Oncology. 154: e6. DOI: 10.1016/J.Ygyno.2019.03.169 |
0.324 |
|
| 2018 |
Winham SJ, Larson NB, Armasu SM, Fogarty ZC, Larson MC, McCauley BM, Wang C, Lawrenson K, Gayther S, Cunningham JM, Fridley BL, Goode EL. Molecular signatures of X chromosome inactivation and associations with clinicaloutcomes in epithelial ovarian cancer. Human Molecular Genetics. PMID 30576442 DOI: 10.1093/Hmg/Ddy444 |
0.436 |
|
| 2018 |
Abbas-Aghababazadeh F, Li Q, Fridley BL. Comparison of normalization approaches for gene expression studies completed with high-throughput sequencing. Plos One. 13: e0206312. PMID 30379879 DOI: 10.1371/Journal.Pone.0206312 |
0.335 |
|
| 2018 |
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 |
0.418 |
|
| 2018 |
O'Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, Auer PL, Beckmann MW, Black A, Bolla MK, Brauch H, Brenner H, Brinton L, Buchanan DD, Burwinkel B, ... ... Fridley BL, et al. Identification of nine new susceptibility loci for endometrial cancer. Nature Communications. 9: 3166. PMID 30093612 DOI: 10.1038/S41467-018-05427-7 |
0.512 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Fridley BL, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.393 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, ... ... Fridley BL, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.311 |
|
| 2018 |
Natanzon Y, Earp M, Cunningham JM, Kalli KR, Wang C, Armasu SM, Larson MC, Bowtell DD, Garsed DW, Fridley BL, Winham SJ, Goode EL. Genomic Analysis Using Regularized Regression in High-Grade Serous Ovarian Cancer. Cancer Informatics. 17: 1176935118755341. PMID 29434467 DOI: 10.1177/1176935118755341 |
0.443 |
|
| 2018 |
Gonzalez VJ, Abbas-Aghababazadeh F, Fridley BL, Ghansah T, Saligan LN. Expression of Sestrin Genes in Radiotherapy for Prostate Cancer and Its Association With Fatigue: A Proof-of-Concept Study. Biological Research For Nursing. 1099800417749319. PMID 29325451 DOI: 10.1177/1099800417749319 |
0.358 |
|
| 2018 |
Kelemen LE, Brenton JD, Bowtell DD, Fridley BL. Abstract A14: TP53 missense mutations associate with different metabolic pathways Clinical Cancer Research. 24. DOI: 10.1158/1557-3265.Ovca17-A14 |
0.351 |
|
| 2017 |
Larson NB, Fogarty ZC, Larson MC, Kalli KR, Lawrenson K, Gayther S, Fridley BL, Goode EL, Winham SJ. An integrative approach to assess X-chromosome inactivation using allele-specific expression with applications to epithelial ovarian cancer. Genetic Epidemiology. PMID 29119601 DOI: 10.1002/Gepi.22091 |
0.399 |
|
| 2017 |
Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, et al. Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity. Oncotarget. 8: 78133-78143. PMID 29100455 DOI: 10.18632/Oncotarget.17726 |
0.457 |
|
| 2017 |
Goode EL, Block MS, Kalli KR, Vierkant RA, Chen W, Fogarty ZC, Gentry-Maharaj A, Toloczko A, Hein A, Bouligny AL, Jensen A, Osorio A, Hartkopf AD, Ryan A, ... ... Fridley BL, et al. Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer. Jama Oncology. e173290. PMID 29049607 DOI: 10.1001/Jamaoncol.2017.3290 |
0.325 |
|
| 2017 |
Dicks E, Song H, Ramus SJ, Oudenhove EV, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Group AS, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, et al. Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene. Oncotarget. 8: 50930-50940. PMID 28881617 DOI: 10.18632/Oncotarget.15871 |
0.423 |
|
| 2017 |
Hein A, Rack B, Li L, Ekici AB, Reis A, Lux MP, Cunningham JM, Rübner M, Fridley BL, Schneeweiss A, Tesch H, Lichtenegger W, Fehm T, Heinrich G, Rezai M, et al. Genetic Breast Cancer Susceptibility Variants and Prognosis in the Prospectively Randomized SUCCESS A Study. Geburtshilfe Und Frauenheilkunde. 77: 651-659. PMID 28757652 DOI: 10.1055/S-0042-113189 |
0.445 |
|
| 2017 |
Liu G, Lee S, Lee AW, Wu AH, Bandera EV, Jensen A, Anne Rossing M, Moysich KB, Chang-Claude J, Doherty J, Gentry-Maharaj A, Kiemeney L, Gayther SA, Modugno F, Massuger L, ... ... Fridley B, et al. Robust Tests for Additive Gene-Environment Interaction in Case-Control Studies Using Gene-Environment Independence. American Journal of Epidemiology. PMID 28633381 DOI: 10.1093/Aje/Kwx243 |
0.35 |
|
| 2017 |
Fasching PA, Häberle L, Rack B, Li L, Hein A, Ekici AB, Reis A, Lux MP, Cunningham JM, Ruebner M, Jenkins G, Fridley B, Schneeweiss A, Tesch H, Lichtenegger W, et al. Clinical validation of genetic variants associated with in vitro chemotherapy-related lymphoblastoid cell toxicity. Oncotarget. PMID 28537877 DOI: 10.18632/oncotarget.17726 |
0.352 |
|
| 2017 |
Chalise P, Fridley BL. Integrative clustering of multi-level 'omic data based on non-negative matrix factorization algorithm. Plos One. 12: e0176278. PMID 28459819 DOI: 10.1371/Journal.Pone.0176278 |
0.353 |
|
| 2017 |
Earp MA, Raghavan R, Li Q, Dai J, Winham SJ, Cunningham JM, Natanzon Y, Kalli KR, Hou X, Weroha SJ, Haluska P, Lawrenson K, Gayther SA, Wang C, Goode EL, ... Fridley BL, et al. Characterization of fusion genes in common and rare epithelial ovarian cancer histologic subtypes. Oncotarget. PMID 28423358 DOI: 10.18632/Oncotarget.16781 |
0.332 |
|
| 2017 |
Dicks E, Song H, Ramus SJ, Van Oudenhove E, Tyrer JP, Intermaggio MP, Kar S, Harrington P, Bowtell DD, Study Group A, Cicek MS, Cunningham JM, Fridley BL, Alsop J, Jimenez-Linan M, et al. Germline whole exome sequencing and large-scale replication identifies FANCM as a likely high grade serous ovarian cancer susceptibility gene. Oncotarget. PMID 28404948 DOI: 10.18632/oncotarget.15871 |
0.311 |
|
| 2017 |
Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, ... ... Fridley BL, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/Ijc.30600 |
0.348 |
|
| 2017 |
Winham SJ, Larson NB, Armasu SM, Fogarty ZC, Larson MC, Kalli KR, Lawrenson K, Gayther S, Fridley BL, Goode EL. Abstract 2420: Integrative analyses of gene expression, DNA methylation, genotype and copy number alterations characterize X-chromosome inactivation in ovarian cancer Cancer Research. 77: 2420-2420. DOI: 10.1158/1538-7445.Am2017-2420 |
0.417 |
|
| 2016 |
Meier R, Graw S, Usset J, Raghavan R, Dai J, Chalise P, Ellis S, Fridley B, Koestler D. An ensemble-based Cox proportional hazards regression framework for predicting survival in metastatic castration-resistant prostate cancer (mCRPC) patients. F1000research. 5: 2677. PMID 28413609 DOI: 10.12688/F1000Research.8226.1 |
0.328 |
|
| 2016 |
Niu N, Liu T, Cairns J, Ly RC, Tan X, Deng M, Fridley BL, Kalari KR, Abo RP, Jenkins G, Batzler A, Carlson EE, Barman P, Moran S, Heyn H, et al. Metformin pharmacogenomics: a genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines. Human Molecular Genetics. 25: 4819-4834. PMID 28173075 DOI: 10.1093/Hmg/Ddw301 |
0.451 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Fridley B, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.47 |
|
| 2016 |
Raghavan R, Hyter S, Pathak HB, Godwin AK, Konecny G, Wang C, Goode EL, Fridley BL. Drug discovery using clinical outcome-based Connectivity Mapping: application to ovarian cancer. Bmc Genomics. 17: 811. PMID 27756228 DOI: 10.1186/S12864-016-3149-5 |
0.416 |
|
| 2016 |
Li L, Zhang JW, Jenkins G, Xie F, Carlson EE, Fridley BL, Bamlet WR, Petersen GM, McWilliams RR, Wang L. Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer. Pharmacogenetics and Genomics. PMID 27749787 DOI: 10.1097/Fpc.0000000000000241 |
0.394 |
|
| 2016 |
Ross-Adams H, Ball S, Lawrenson K, Halim S, Russell R, Wells C, Strand SH, Ørntoft TF, Larson M, Armasu S, Massie CE, Asim M, Mortensen MM, Borre M, Woodfine K, ... ... Fridley BL, et al. HNF1B variants associate with promoter methylation and regulate gene networks activated in prostate and ovarian cancer. Oncotarget. PMID 27732966 DOI: 10.18632/Oncotarget.12543 |
0.489 |
|
| 2016 |
Way GP, Rudd J, Wang C, Hamidi H, Fridley BL, Konecny GE, Goode EL, Greene CS, Doherty JA. Comprehensive Cross-Population Analysis of High-Grade Serous Ovarian Cancer Supports No More Than Three Subtypes. G3 (Bethesda, Md.). PMID 27729437 DOI: 10.1534/G3.116.033514 |
0.365 |
|
| 2016 |
Niu N, Liu T, Cairns J, Ly RC, Tan X, Deng M, Fridley BL, Kalari KR, Abo RP, Jenkins G, Batzler A, Carlson EE, Barman P, Moran S, Heyn H, et al. Metformin Pharmacogenomics: A genome-wide association study to identify genetic and epigenetic biomarkers involved in metformin anticancer response using human lymphoblastoid cell lines. Human Molecular Genetics. PMID 27616566 DOI: 10.1093/hmg/ddw301 |
0.345 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... ... Fridley BL, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.373 |
|
| 2016 |
Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... ... Fridley BL, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207 |
0.392 |
|
| 2016 |
Painter JN, O'Mara TA, Marquart L, Webb PM, Attia J, Medland SE, Cheng T, Dennis J, Holliday EG, McEvoy M, Scott RJ, Ahmed S, Healey CS, Shah M, Gorman M, ... ... Fridley BL, et al. Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27550749 DOI: 10.1158/1055-9965.Epi-16-0147 |
0.372 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, ... ... Fridley BL, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.421 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, ... ... Fridley BL, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.429 |
|
| 2016 |
Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, ... ... Fridley BL, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196 |
0.475 |
|
| 2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Fridley BL, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.427 |
|
| 2016 |
Wang C, Winterhoff BJ, Kalli KR, Block MS, Armasu SM, Larson MC, Chen HW, Keeney GL, Hartmann LC, Shridhar V, Konecny GE, Goode EL, Fridley BL. Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer. British Journal of Cancer. PMID 27253175 DOI: 10.1038/Bjc.2016.124 |
0.4 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Fridley BL, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.42 |
|
| 2016 |
Cheng TH, Thompson DJ, O'Mara TA, Painter JN, Glubb DM, Flach S, Lewis A, French JD, Freeman-Mills L, Church D, Gorman M, Martin L, Hodgson S, Webb PM, ... ... Fridley BL, et al. Five endometrial cancer risk loci identified through genome-wide association analysis. Nature Genetics. PMID 27135401 DOI: 10.1038/Ng.3562 |
0.471 |
|
| 2016 |
Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... ... Fridley BL, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9 |
0.399 |
|
| 2016 |
Fridley BL, Ghosh TM, Wang A, Raghavan R, Dai J, Goode EL, Lamba JK. Genome-Wide Study of Response to Platinum, Taxane, and Combination Therapy in Ovarian Cancer: In vitro Phenotypes, Inherited Variation, and Disease Recurrence. Frontiers in Genetics. 7: 37. PMID 27047539 DOI: 10.3389/Fgene.2016.00037 |
0.38 |
|
| 2016 |
Chalise P, Raghavan R, Fridley BL. InterSIM: Simulation tool for multiple integrative 'omic datasets'. Computer Methods and Programs in Biomedicine. 128: 69-74. PMID 27040832 DOI: 10.1016/J.Cmpb.2016.02.011 |
0.368 |
|
| 2016 |
Winterhoff B, Hamidi H, Wang C, Kalli KR, Fridley BL, Dering J, Chen HW, Cliby WA, Wang HJ, Dowdy S, Gostout BS, Keeney GL, Goode EL, Konecny GE. Molecular classification of high grade endometrioid and clear cell ovarian cancer using TCGA gene expression signatures. Gynecologic Oncology. 141: 95-100. PMID 27016234 DOI: 10.1016/J.Ygyno.2016.02.023 |
0.407 |
|
| 2016 |
Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, ... ... Fridley BL, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.Epi-15-1039 |
0.333 |
|
| 2016 |
Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, ... ... Fridley BL, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/J.Canep.2016.01.012 |
0.382 |
|
| 2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Fridley BL, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.498 |
|
| 2016 |
French JD, Johnatty SE, Lu Y, Beesley J, Gao B, Kalimutho M, Henderson MJ, Russell AJ, Kar S, Chen X, Hillman KM, Kaufmann S, Sivakumaran H, O'Reilly M, Wang C, ... ... Fridley B, et al. Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer. Oncotarget. PMID 26840454 DOI: 10.18632/Oncotarget.7047 |
0.479 |
|
| 2016 |
Pharoah PD, Song H, Dicks E, Intermaggio MP, Harrington P, Baynes C, Alsop K, Bogdanova N, Cicek MS, Cunningham JM, Fridley BL, Gentry-Maharaj A, Hillemanns P, Lele S, et al. PPM1D Mosaic Truncating Variants in Ovarian Cancer Cases May Be Treatment-Related Somatic Mutations. Journal of the National Cancer Institute. 108. PMID 26823519 DOI: 10.1093/Jnci/Djv347 |
0.354 |
|
| 2016 |
Jatoi A, Vierkant RA, Hawthorne KM, Block MS, Ramus SJ, Larson NB, Fridley BL, Goode EL. Clinical and Emergent Biomarkers and Their Relationship to the Prognosis of Ovarian Cancer. Oncology. PMID 26780780 DOI: 10.1159/000442710 |
0.395 |
|
| 2016 |
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... ... Fridley BL, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240 |
0.368 |
|
| 2016 |
Fridley BL, Dai J, Raghavan R, Wang C, Lu P, Winham S, Earp M, Lawrenson K, Gayther SA, Kalli KR, Goode EL. Abstract 1833: Transcriptome characterization of high grade serous and endometrioid epithelial ovarian cancer tumors Cancer Research. 76: 1833-1833. DOI: 10.1158/1538-7445.Am2016-1833 |
0.404 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli G, Bandera EV, Berchuck A, ... ... Fridley BL, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium Obstetrical and Gynecological Survey. 71: 528-530. DOI: 10.1097/Ogx.0000000000000357 |
0.391 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Fridley BL, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.431 |
|
| 2015 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Fridley BL, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B |
0.351 |
|
| 2015 |
Bartlett TE, Jones A, Goode EL, Fridley BL, Cunningham JM, Berns EM, Wik E, Salvesen HB, Davidson B, Trope CG, Lambrechts S, Vergote I, Widschwendter M. Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers. Plos One. 10: e0143178. PMID 26629914 DOI: 10.1371/Journal.Pone.0143178 |
0.37 |
|
| 2015 |
Cheng TH, Thompson D, Painter J, O'Mara T, Gorman M, Martin L, Palles C, Jones A, Buchanan DD, Ko Win A, Hopper J, Jenkins M, Lindor NM, Newcomb PA, Gallinger S, ... ... Fridley BL, et al. Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1. Scientific Reports. 5: 17369. PMID 26621817 DOI: 10.1038/Srep17369 |
0.505 |
|
| 2015 |
Thompson DJ, O'Mara TA, Glubb DM, Painter JN, Cheng T, Folkerd E, Doody D, Dennis J, Webb PM, Gorman M, Martin L, Hodgson S, Michailidou K, Tyrer JP, Maranian MJ, ... ... Fridley BL, et al. CYP19A1 fine-mapping and Mendelian randomisation: estradiol is causal for endometrial cancer. Endocrine-Related Cancer. PMID 26574572 DOI: 10.1530/Erc-15-0386 |
0.508 |
|
| 2015 |
Teschendorff AE, Lee SH, Jones A, Fiegl H, Kalwa M, Wagner W, Chindera K, Evans I, Dubeau L, Orjalo A, Horlings HM, Niederreiter L, Kaser A, Yang W, Goode EL, ... Fridley BL, et al. HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer. Genome Medicine. 7: 108. PMID 26497652 DOI: 10.1186/S13073-015-0233-4 |
0.357 |
|
| 2015 |
Jatoi A, Foster NR, Kalli KR, Vierkant RA, Zhang Z, Larson MC, Fridley B, Goode EL. Prior oral contraceptive use in ovarian cancer patients: assessing associations with overall and progression-free survival. Bmc Cancer. 15: 711. PMID 26471496 DOI: 10.1186/S12885-015-1774-Z |
0.406 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Fridley BL, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.41 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Fridley BL, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.486 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Fridley BL, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.485 |
|
| 2015 |
O'Mara TA, Glubb DM, Painter JN, Cheng T, Dennis J, Attia J, Holliday EG, McEvoy M, Scott RJ, Ashton K, Proietto T, Otton G, Shah M, Ahmed S, ... ... Fridley BL, et al. Comprehensive genetic assessment of the ESR1 locus identifies a risk region for endometrial cancer. Endocrine-Related Cancer. 22: 851-61. PMID 26330482 DOI: 10.1530/Erc-15-0319 |
0.508 |
|
| 2015 |
Ramus SJ, Song H, Dicks E, Tyrer JP, Rosenthal AN, Intermaggio MP, Fraser L, Gentry-Maharaj A, Hayward J, Philpott S, Anderson C, Edlund CK, Conti D, Harrington P, Barrowdale D, ... ... Fridley BL, et al. Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer. Journal of the National Cancer Institute. 107. PMID 26315354 DOI: 10.1093/Jnci/Djv214 |
0.415 |
|
| 2015 |
Fabian CJ, Kimler BF, Phillips TA, Nydegger JL, Kreutzjans AL, Carlson SE, Hidaka BH, Metheny T, Zalles CM, Mills GB, Powers KR, Sullivan DK, Petroff BK, Hensing WL, Fridley BL, et al. Modulation of Breast Cancer Risk Biomarkers by High-Dose Omega-3 Fatty Acids: Phase II Pilot Study in Postmenopausal Women. Cancer Prevention Research (Philadelphia, Pa.). 8: 922-31. PMID 26276744 DOI: 10.1158/1940-6207.Capr-14-0336 |
0.328 |
|
| 2015 |
Song H, Dicks E, Ramus SJ, Tyrer JP, Intermaggio MP, Hayward J, Edlund CK, Conti D, Harrington P, Fraser L, Philpott S, Anderson C, Rosenthal A, Gentry-Maharaj A, Bowtell DD, ... ... Fridley BL, et al. Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 33: 2901-7. PMID 26261251 DOI: 10.1200/Jco.2015.61.2408 |
0.399 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Fridley BL, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.459 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Fridley BL, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.459 |
|
| 2015 |
Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... ... Fridley BL, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 |
0.471 |
|
| 2015 |
Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, ... ... Fridley BL, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 26151456 DOI: 10.1038/Bjc.2015.245 |
0.412 |
|
| 2015 |
Chauhan L, Jenkins GD, Bhise N, Feldberg T, Mitra-Ghosh T, Fridley BL, Lamba JK. Genome-wide association analysis identified splicing single nucleotide polymorphism in CFLAR predictive of triptolide chemo-sensitivity. Bmc Genomics. 16: 483. PMID 26121980 DOI: 10.1186/S12864-015-1614-1 |
0.321 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Fridley BL, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.519 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Fridley BL, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.455 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Fridley BL, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.354 |
|
| 2015 |
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Fridley BL, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017 |
0.438 |
|
| 2015 |
Carvajal-Carmona LG, O'Mara TA, Painter JN, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K, Healey CS, Pooley K, Beesley J, Cheng T, Jones A, Howarth K, ... ... Fridley BL, et al. Candidate locus analysis of the TERT-CLPTM1L cancer risk region on chromosome 5p15 identifies multiple independent variants associated with endometrial cancer risk. Human Genetics. 134: 231-45. PMID 25487306 DOI: 10.1007/S00439-014-1515-4 |
0.515 |
|
| 2015 |
Candido-dos-Reis FJ, Song H, Goode EL, Cunningham JM, Fridley BL, Larson MC, Alsop K, Dicks E, Harrington P, Ramus SJ, de Fazio A, Mitchell G, Fereday S, Bolton KL, Gourley C, et al. Germline mutation in BRCA1 or BRCA2 and ten-year survival for women diagnosed with epithelial ovarian cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 21: 652-7. PMID 25398451 DOI: 10.1158/1078-0432.Ccr-14-2497 |
0.345 |
|
| 2015 |
Painter JN, O'Mara TA, Batra J, Cheng T, Lose FA, Dennis J, Michailidou K, Tyrer JP, Ahmed S, Ferguson K, Healey CS, Kaufmann S, Hillman KM, Walpole C, Moya L, ... ... Fridley BL, et al. Fine-mapping of the HNF1B multicancer locus identifies candidate variants that mediate endometrial cancer risk. Human Molecular Genetics. 24: 1478-92. PMID 25378557 DOI: 10.1093/Hmg/Ddu552 |
0.516 |
|
| 2015 |
Fridley BL, Raghavan R, Konecny GE, Wang C, Goode EL, Pathak HB, Hyter S. Abstract 4853: A bioinformatics approach to drug discovery: patient based connectivity mapping Cancer Research. 75: 4853-4853. DOI: 10.1158/1538-7445.Am2015-4853 |
0.431 |
|
| 2015 |
Usset J, Fridley B, Goode E, Schildkraut J, Pharoah P. Abstract 4684: Assessment of multifactor gene-environment interactions and ovarian cancer risk: SNPs, obesity, and hormone-related risk factors Cancer Research. 75: 4684-4684. DOI: 10.1158/1538-7445.Am2015-4684 |
0.451 |
|
| 2015 |
Winham SJ, Fridley BL, Larson MC, Fogarty Z, Berchuck A, Chen YA, Lin H, Chenevix-Trench G, Permuth-Wey J, Sellers TA, Pirie A, Goode EL. Abstract 4636: Investigation of exome variants associated with overall survival in ovarian cancer Cancer Research. 75: 4636-4636. DOI: 10.1158/1538-7445.Am2015-4636 |
0.506 |
|
| 2014 |
Köbel M, Madore J, Ramus SJ, Clarke BA, Pharoah PD, Deen S, Bowtell DD, Odunsi K, Menon U, Morrison C, Lele S, Bshara W, Sucheston L, Beckmann MW, Hein A, ... ... Fridley BL, et al. Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study. British Journal of Cancer. 111: 2297-307. PMID 25349970 DOI: 10.1038/Bjc.2014.567 |
0.356 |
|
| 2014 |
Lamba JK, Fridley BL, Ghosh TM, Yu Q, Mehta G, Gupta P. Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small-cell lung cancer. Pharmacogenomics. 15: 1565-74. PMID 25340731 DOI: 10.2217/Pgs.14.107 |
0.387 |
|
| 2014 |
Chalise P, Koestler DC, Bimali M, Yu Q, Fridley BL. Integrative clustering methods for high-dimensional molecular data. Translational Cancer Research. 3: 202-216. PMID 25243110 DOI: 10.3978/J.Issn.2218-676X.2014.06.03 |
0.321 |
|
| 2014 |
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Fridley BL, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068 |
0.335 |
|
| 2014 |
Wang Z, Zhu B, Zhang M, Parikh H, Jia J, Chung CC, Sampson JN, Hoskins JW, Hutchinson A, Burdette L, Ibrahim A, Hautman C, Raj PS, Abnet CC, Adjei AA, ... ... Fridley BL, et al. Imputation and subset-based association analysis across different cancer types identifies multiple independent risk loci in the TERT-CLPTM1L region on chromosome 5p15.33. Human Molecular Genetics. 23: 6616-33. PMID 25027329 DOI: 10.1093/Hmg/Ddu363 |
0.462 |
|
| 2014 |
Hedditch EL, Gao B, Russell AJ, Lu Y, Emmanuel C, Beesley J, Johnatty SE, Chen X, Harnett P, George J, Williams RT, Flemming C, Lambrechts D, Despierre E, ... ... Fridley B, et al. ABCA transporter gene expression and poor outcome in epithelial ovarian cancer. Journal of the National Cancer Institute. 106. PMID 24957074 DOI: 10.1093/Jnci/Dju149 |
0.448 |
|
| 2014 |
Winham SJ, Armasu SM, Cicek MS, Larson MC, Cunningham JM, Kalli KR, Fridley BL, Goode EL. Genome-wide investigation of regional blood-based DNA methylation adjusted for complete blood counts implicates BNC2 in ovarian cancer. Genetic Epidemiology. 38: 457-66. PMID 24853948 DOI: 10.1002/Gepi.21815 |
0.419 |
|
| 2014 |
Fridley BL, Armasu SM, Cicek MS, Larson MC, Wang C, Winham SJ, Kalli KR, Koestler DC, Rider DN, Shridhar V, Olson JE, Cunningham JM, Goode EL. Methylation of leukocyte DNA and ovarian cancer: relationships with disease status and outcome. Bmc Medical Genomics. 7: 21. PMID 24774302 DOI: 10.1186/1755-8794-7-21 |
0.375 |
|
| 2014 |
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, et al. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research. 2: 332-40. PMID 24764580 DOI: 10.1158/2326-6066.Cir-13-0136 |
0.48 |
|
| 2014 |
Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, ... ... Fridley BL, et al. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1421-7. PMID 24740199 DOI: 10.1158/1055-9965.Epi-13-0962 |
0.437 |
|
| 2014 |
Song H, Cicek MS, Dicks E, Harrington P, Ramus SJ, Cunningham JM, Fridley BL, Tyrer JP, Alsop J, Jimenez-Linan M, Gayther SA, Goode EL, Pharoah PD. The contribution of deleterious germline mutations in BRCA1, BRCA2 and the mismatch repair genes to ovarian cancer in the population. Human Molecular Genetics. 23: 4703-9. PMID 24728189 DOI: 10.1093/Hmg/Ddu172 |
0.306 |
|
| 2014 |
Wang C, Cicek MS, Charbonneau B, Kalli KR, Armasu SM, Larson MC, Konecny GE, Winterhoff B, Fan JB, Bibikova M, Chien J, Shridhar V, Block MS, Hartmann LC, Visscher DW, ... ... Fridley BL, et al. Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer. Cancer Research. 74: 3084-91. PMID 24728075 DOI: 10.1158/0008-5472.Can-13-3198 |
0.361 |
|
| 2014 |
Fridley BL, Koestler DC, Koeslter DC, Godwin AK. Individualizing care for ovarian cancer patients using big data. Journal of the National Cancer Institute. 106. PMID 24700802 DOI: 10.1093/Jnci/Dju080 |
0.35 |
|
| 2014 |
Matimba A, Li F, Livshits A, Cartwright CS, Scully S, Fridley BL, Jenkins G, Batzler A, Wang L, Weinshilboum R, Lennard L. Thiopurine pharmacogenomics: association of SNPs with clinical response and functional validation of candidate genes. Pharmacogenomics. 15: 433-47. PMID 24624911 DOI: 10.2217/Pgs.13.226 |
0.359 |
|
| 2014 |
Laurie CC, Laurie CA, Smoley SA, Carlson EE, Flinn I, Fridley BL, Greisman HA, Gribben JG, Jelinek DF, Nelson SC, Paietta E, Schaid D, Sun Z, Tallman MS, Weinshilboum R, et al. Acquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants. Cancer Genetics. 207: 19-30. PMID 24613276 DOI: 10.1016/J.Cancergen.2014.01.004 |
0.324 |
|
| 2014 |
Cunningham JM, Cicek MS, Larson NB, Davila J, Wang C, Larson MC, Song H, Dicks EM, Harrington P, Wick M, Winterhoff BJ, Hamidi H, Konecny GE, Chien J, Bibikova M, ... ... Fridley BL, et al. Clinical characteristics of ovarian cancer classified by BRCA1, BRCA2, and RAD51C status. Scientific Reports. 4: 4026. PMID 24504028 DOI: 10.1038/Srep04026 |
0.376 |
|
| 2014 |
Li L, Fridley BL, Kalari K, Niu N, Jenkins G, Batzler A, Abo RP, Schaid D, Wang L. Discovery of genetic biomarkers contributing to variation in drug response of cytidine analogues using human lymphoblastoid cell lines Bmc Genomics. 15. PMID 24483146 DOI: 10.1186/1471-2164-15-93 |
0.396 |
|
| 2014 |
Koestler DC, Chalise P, Cicek MS, Cunningham JM, Armasu S, Larson MC, Chien J, Block M, Kalli KR, Sellers TA, Fridley BL, Goode EL. Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer. Bmc Medical Genomics. 7: 8. PMID 24479488 DOI: 10.1186/1755-8794-7-8 |
0.424 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Fridley BL, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.528 |
|
| 2014 |
Fridley BL, Abo R, Tan XL, Jenkins GD, Batzler A, Moyer AM, Biernacka JM, Wang L. Integrative gene set analysis: Application to platinum pharmacogenomics Omics a Journal of Integrative Biology. 18: 34-41. PMID 24199607 DOI: 10.1089/Omi.2013.0099 |
0.439 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Fridley BL, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.49 |
|
| 2014 |
Larson NB, Jenkins GD, Larson MC, Vierkant RA, Sellers TA, Phelan CM, Schildkraut JM, Sutphen R, Pharoah PP, Gayther SA, Wentzensen N, Goode EL, Fridley BL. Kernel canonical correlation analysis for assessing gene-gene interactions and application to ovarian cancer. European Journal of Human Genetics : Ejhg. 22: 126-31. PMID 23591404 DOI: 10.1038/Ejhg.2013.69 |
0.432 |
|
| 2014 |
Dudenkov TM, Ingle JN, Buzdar A, Robson ME, Kubo M, Batzler A, Jenkins GD, Pietrzak TL, Carlson EE, Fridley BL, Goetz MP, Northfelt DW, Perez EA, Williard CV, Kalari KR, et al. Genes associated with serum estrone, estrone conjugates, and androstenedione concentrations in postmenopausal women with estrogen receptor-positive breast cancer. Journal of Clinical Oncology. 32: 593-593. DOI: 10.1200/Jco.2014.32.15_Suppl.593 |
0.398 |
|
| 2014 |
Fridley BL, Ghosh TM, Wang A, Goode EL, Lamba J. Abstract 5565: In vitro pharmacogenomic study of ovarian cancer finds novel genetic variants associated with response to platinum and taxane therapies Cancer Research. 74: 5565-5565. DOI: 10.1158/1538-7445.Am2014-5565 |
0.453 |
|
| 2014 |
Lamba JK, Fridley BL, Ghosh TM, Yu Q, Mehta G, Gupta P. Abstract 5554: Genetic variation in platinating agent and taxane pathway genes as predictors of outcome and toxicity in advanced non-small cell lung cancer Cancer Research. 74: 5554-5554. DOI: 10.1158/1538-7445.Am2014-5554 |
0.47 |
|
| 2014 |
Buckley MA, Shen HC, Mendoza-Fandino GA, Woods NT, Gjyshi A, French J, Lawrenson K, Song H, Tyrer J, Carvalho RS, Valle A, Chen A, Yoder S, Bloom G, Tsai Y, ... ... Fridley B, et al. Abstract 3285: Functional analysis of the 9p22 locus implicates the transcriptional regulation ofBNC2as a mechanism in ovarian cancer predisposition Cancer Research. 74: 3285-3285. DOI: 10.1158/1538-7445.Am2014-3285 |
0.497 |
|
| 2014 |
Koestler DC, Chalise P, Cicek MS, Cunningham JM, Armasu S, Larson MC, Chien J, Block M, Kalli KR, Sellers TA, Goode EL, Fridley BL. Abstract 260: Integrative genomic analysis identifies epigenetic marks that mediate genetic risk for epithelial ovarian cancer Cancer Research. 74: 260-260. DOI: 10.1158/1538-7445.Am2014-260 |
0.482 |
|
| 2013 |
Fridley BL, Jenkins GD, Grill DE, Kennedy RB, Poland GA, Oberg AL. Soft truncation thresholding for gene set analysis of RNA-seq data: application to a vaccine study. Scientific Reports. 3: 2898. PMID 24104466 DOI: 10.1038/Srep02898 |
0.313 |
|
| 2013 |
Jiang J, Fridley BL, Feng Q, Abo RP, Brisbin A, Batzler A, Jenkins G, Long PA, Wang L. Genome-wide association study for biomarker identification of Rapamycin and Everolimus using a lymphoblastoid cell line system. Frontiers in Genetics. 4: 166. PMID 24009623 DOI: 10.3389/Fgene.2013.00166 |
0.426 |
|
| 2013 |
Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L. Contribution of FKBP5 genetic variation to gemcitabine treatment and survival in pancreatic adenocarcinoma. Plos One. 8: e70216. PMID 23936393 DOI: 10.1371/Journal.Pone.0070216 |
0.353 |
|
| 2013 |
Brisbin A, Fridley BL. Bayseian genomic models for the incorporation of pathway topology knowledge into association studies. Statistical Applications in Genetics and Molecular Biology. 12: 505-16. PMID 23934611 DOI: 10.1515/Sagmb-2012-0061 |
0.329 |
|
| 2013 |
Johnatty SE, Beesley J, Gao B, Chen X, Lu Y, Law MH, Henderson MJ, Russell AJ, Hedditch EL, Emmanuel C, Fereday S, Webb PM, Goode EL, Vierkant RA, ... Fridley BL, et al. ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecologic Oncology. 131: 8-14. PMID 23917080 DOI: 10.1016/J.Ygyno.2013.07.107 |
0.463 |
|
| 2013 |
Köbel M, Kalloger SE, Lee S, Duggan MA, Kelemen LE, Prentice L, Kalli KR, Fridley BL, Visscher DW, Keeney GL, Vierkant RA, Cunningham JM, Chow C, Ness RB, Moysich K, et al. Biomarker-based ovarian carcinoma typing: a histologic investigation in the ovarian tumor tissue analysis consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1677-86. PMID 23880734 DOI: 10.1158/1055-9965.Epi-13-0391 |
0.305 |
|
| 2013 |
Sieh W, Köbel M, Longacre TA, Bowtell DD, deFazio A, Goodman MT, Høgdall E, Deen S, Wentzensen N, Moysich KB, Brenton JD, Clarke BA, Menon U, Gilks CB, Kim A, ... ... Fridley BL, et al. Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. The Lancet. Oncology. 14: 853-62. PMID 23845225 DOI: 10.1016/S1470-2045(13)70253-5 |
0.381 |
|
| 2013 |
DeRycke MS, Gunawardena SR, Middha S, Asmann YW, Schaid DJ, McDonnell SK, Riska SM, Eckloff BW, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Cicek MS, Jenkins MA, Duggan DJ, et al. Identification of novel variants in colorectal cancer families by high-throughput exome sequencing. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 1239-51. PMID 23637064 DOI: 10.1158/1055-9965.Epi-12-1226 |
0.368 |
|
| 2013 |
Cicek MS, Koestler DC, Fridley BL, Kalli KR, Armasu SM, Larson MC, Wang C, Winham SJ, Vierkant RA, Rider DN, Block MS, Klotzle B, Konecny G, Winterhoff BJ, Hamidi H, et al. Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel. Human Molecular Genetics. 22: 3038-47. PMID 23571109 DOI: 10.1093/Hmg/Ddt160 |
0.399 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Fridley BL, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.459 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.507 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.502 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Fridley BL, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.46 |
|
| 2013 |
Liu M, Ingle JN, Fridley BL, Buzdar AU, Robson ME, Kubo M, Wang L, Batzler A, Jenkins GD, Pietrzak TL, Carlson EE, Goetz MP, Northfelt DW, Perez EA, Williard CV, et al. TSPYL5 SNPs: association with plasma estradiol concentrations and aromatase expression. Molecular Endocrinology (Baltimore, Md.). 27: 657-70. PMID 23518928 DOI: 10.1210/Me.2012-1397 |
0.454 |
|
| 2013 |
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, ... ... Fridley BL, et al. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 987-92. PMID 23513043 DOI: 10.1158/1055-9965.Epi-13-0028 |
0.494 |
|
| 2013 |
Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, ... ... Fridley BL, et al. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 880-90. PMID 23462924 DOI: 10.1158/1055-9965.Epi-12-1030-T |
0.41 |
|
| 2013 |
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... ... Fridley BL, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4 |
0.383 |
|
| 2013 |
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, ... ... Fridley BL, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer. 20: 251-62. PMID 23404857 DOI: 10.1530/Erc-12-0395 |
0.436 |
|
| 2013 |
Goode EL, DeRycke M, Kalli KR, Oberg AL, Cunningham JM, Maurer MJ, Fridley BL, Armasu SM, Serie DJ, Ramar P, Goergen K, Vierkant RA, Rider DN, Sicotte H, Wang C, et al. Inherited variants in regulatory T cell genes and outcome of ovarian cancer. Plos One. 8: e53903. PMID 23382860 DOI: 10.1371/Journal.Pone.0053903 |
0.471 |
|
| 2013 |
Rice T, Zheng S, Decker PA, Walsh KM, Bracci P, Xiao Y, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Hsuang G, Wiemels JL, Tihan T, Pico AR, Prados MD, ... ... Fridley BL, et al. Inherited variant on chromosome 11q23 increases susceptibility to IDH-mutated but not IDH-normal gliomas regardless of grade or histology. Neuro-Oncology. 15: 535-41. PMID 23361564 DOI: 10.1093/Neuonc/Nos324 |
0.347 |
|
| 2013 |
Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM. Survival is associated with genetic variation in inflammatory pathway genes among patients with resected and unresected pancreatic cancer. Annals of Surgery. 257: 1096-102. PMID 23360921 DOI: 10.1097/Sla.0B013E318275B7E5 |
0.404 |
|
| 2013 |
Ellsworth KA, Moon I, Eckloff BW, Fridley BL, Jenkins GD, Batzler A, Biernacka JM, Abo R, Brisbin A, Ji Y, Hebbring S, Wieben ED, Mrazek DA, Weinshilboum RM, Wang L. FKBP5 genetic variation: association with selective serotonin reuptake inhibitor treatment outcomes in major depressive disorder. Pharmacogenetics and Genomics. 23: 156-66. PMID 23324805 DOI: 10.1097/Fpc.0B013E32835Dc133 |
0.413 |
|
| 2013 |
Biernacka JM, Geske J, Jenkins GD, Colby C, Rider DN, Karpyak VM, Choi DS, Fridley BL. Genome-wide gene-set analysis for identification of pathways associated with alcohol dependence. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 16: 271-8. PMID 22717047 DOI: 10.1017/S1461145712000375 |
0.416 |
|
| 2013 |
Chauhan L, Fridley B, Tanya F, Ghosh TM, Bhise N, Lamba J. Cflar Genetic Variant Resulting In Alternate Splicing Determines Isoform Specific Production Of H-Cflar Protein and Is Predictive Of Cellular Cytoxicity Of Triptolide In Hapmap Lymphoblast and AML Cell Lines Blood. 122: 1287-1287. DOI: 10.1182/Blood.V122.21.1287.1287 |
0.452 |
|
| 2013 |
Charbonneau B, Knutson K, Vierkant RA, Cunningham JM, Fogarty ZC, Kalli KR, Maurer MJ, Oberg AL, Fridley BL, Preston CC, Pharoah PDP, Ramus SJ, Phelan CM, Odunsi K, Moysich K, et al. Abstract 4844: Polymorphisms in regulatory T cell related genes and ovarian cancer survival. Cancer Research. 73: 4844-4844. DOI: 10.1158/1538-7445.Am2013-4844 |
0.476 |
|
| 2013 |
Niu N, Tan X, Fridley BL, Schaid DJ, Abo RP, Batzler A, Carlson EE, Jenkins G, Moran S, Heyn HA, Badosa ME, Wang L. Abstract 2271: Metformin pharmacogenomics: A genome-wide associate study to identify genetic and epigenetic biomarkers involved in metformin response. Cancer Research. 73: 2271-2271. DOI: 10.1158/1538-7445.Am2013-2271 |
0.479 |
|
| 2013 |
lamba JK, Feldberg T, Ghosh TM, Bhise N, Fridley B. Abstract 2214: Genome-wide association analysis identified genetic markers associated with triptolide cellular sensitivity using HapMap LCLs as model system. Cancer Research. 73: 2214-2214. DOI: 10.1158/1538-7445.Am2013-2214 |
0.473 |
|
| 2013 |
Ellsworth KA, Eckloff BW, Li L, Moon I, Fridley BL, Jenkins GD, Carlson E, Brisbin A, Abo R, Bamlet W, Petersen G, Wieben ED, Wang L. Abstract 2209: Contribution ofFKBP5genetic variation to gemcitabine treatment and survival in pancreatic cancer. Cancer Research. 73: 2209-2209. DOI: 10.1158/1538-7445.Am2013-2209 |
0.484 |
|
| 2012 |
Niu N, Schaid DJ, Abo RP, Kalari K, Fridley BL, Feng Q, Jenkins G, Batzler A, Brisbin AG, Cunningham JM, Li L, Sun Z, Yang P, Wang L. Genetic association with overall survival of taxane-treated lung cancer patients - a genome-wide association study in human lymphoblastoid cell lines followed by a clinical association study. Bmc Cancer. 12: 422. PMID 23006423 DOI: 10.1186/1471-2407-12-422 |
0.454 |
|
| 2012 |
Brisbin A, Jenkins GD, Ellsworth KA, Wang L, Fridley BL. Localization of association signal from risk and protective variants in sequencing studies. Frontiers in Genetics. 3: 173. PMID 22973297 DOI: 10.3389/Fgene.2012.00173 |
0.359 |
|
| 2012 |
Poole EM, Gates MA, High BA, Chanock SJ, Cramer DW, Cunningham JM, Fridley BL, Gayther SA, Goode EL, Iversen ES, Lissowska J, Palmieri Weber RT, Pharoah PD, Phelan CM, Ramus SJ, et al. ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. 23: 1805-10. PMID 22961099 DOI: 10.1007/S10552-012-0059-Y |
0.444 |
|
| 2012 |
Jenkins RB, Xiao Y, Sicotte H, Decker PA, Kollmeyer TM, Hansen HM, Kosel ML, Zheng S, Walsh KM, Rice T, Bracci P, McCoy LS, Smirnov I, Patoka JS, Hsuang G, ... ... Fridley BL, et al. A low-frequency variant at 8q24.21 is strongly associated with risk of oligodendroglial tumors and astrocytomas with IDH1 or IDH2 mutation. Nature Genetics. 44: 1122-5. PMID 22922872 DOI: 10.1038/Ng.2388 |
0.401 |
|
| 2012 |
Abo R, Jenkins GD, Wang L, Fridley BL. Identifying the genetic variation of gene expression using gene sets: application of novel gene Set eQTL approach to PharmGKB and KEGG. Plos One. 7: e43301. PMID 22905253 DOI: 10.1371/Journal.Pone.0043301 |
0.393 |
|
| 2012 |
Fridley BL, Chalise P, Tsai YY, Sun Z, Vierkant RA, Larson MC, Cunningham JM, Iversen ES, Fenstermacher D, Barnholtz-Sloan J, Asmann Y, Risch HA, Schildkraut JM, Phelan CM, Sutphen R, et al. Germline copy number variation and ovarian cancer survival. Frontiers in Genetics. 3: 142. PMID 22891074 DOI: 10.3389/Fgene.2012.00142 |
0.433 |
|
| 2012 |
Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Bondy M, Houlston R, Jenkins RB, Wrensch M, Yeager M, Ahlbom A, Albanes D, Andersson U, Freeman LE, ... ... Fridley B, et al. Genome-wide association study of glioma and meta-analysis. Human Genetics. 131: 1877-88. PMID 22886559 DOI: 10.1007/S00439-012-1212-0 |
0.413 |
|
| 2012 |
Ji Y, Nordgren KK, Chai Y, Hebbring SJ, Jenkins GD, Abo RP, Peng Y, Pelleymounter LL, Moon I, Eckloff BW, Chai X, Zhang J, Fridley BL, Yee VC, Wieben ED, et al. Human liver methionine cycle: MAT1A and GNMT gene resequencing, functional genomics, and hepatic genotype-phenotype correlation. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 40: 1984-92. PMID 22807109 DOI: 10.1124/Dmd.112.046953 |
0.386 |
|
| 2012 |
Chalise P, Batzler A, Abo R, Wang L, Fridley BL. Simultaneous analysis of multiple data types in pharmacogenomic studies using weighted sparse canonical correlation analysis. Omics : a Journal of Integrative Biology. 16: 363-73. PMID 22734853 DOI: 10.1089/Omi.2011.0126 |
0.348 |
|
| 2012 |
Cicek MS, Cunningham JM, Fridley BL, Serie DJ, Bamlet WR, Diergaarde B, Haile RW, Le Marchand L, Krontiris TG, Younghusband HB, Gallinger S, Newcomb PA, Hopper JL, Jenkins MA, Casey G, et al. Colorectal cancer linkage on chromosomes 4q21, 8q13, 12q24, and 15q22. Plos One. 7: e38175. PMID 22675446 DOI: 10.1371/Journal.Pone.0038175 |
0.377 |
|
| 2012 |
Raska P, Iversen E, Chen A, Chen Z, Fridley BL, Permuth-Wey J, Tsai YY, Vierkant RA, Goode EL, Risch H, Schildkraut JM, Sellers TA, Barnholtz-Sloan J. European American stratification in ovarian cancer case control data: the utility of genome-wide data for inferring ancestry. Plos One. 7: e35235. PMID 22590501 DOI: 10.1371/Journal.Pone.0035235 |
0.402 |
|
| 2012 |
Stevens KN, Lindstrom S, Scott CG, Thompson D, Sellers TA, Wang X, Wang A, Atkinson E, Rider DN, Eckel-Passow JE, Varghese JS, Audley T, Brown J, Leyland J, Luben RN, ... ... Fridley BL, et al. Identification of a novel percent mammographic density locus at 12q24. Human Molecular Genetics. 21: 3299-305. PMID 22532574 DOI: 10.1093/Hmg/Dds158 |
0.429 |
|
| 2012 |
Breheny P, Chalise P, Batzler A, Wang L, Fridley BL. Genetic association studies of copy-number variation: should assignment of copy number states precede testing? Plos One. 7: e34262. PMID 22493684 DOI: 10.1371/Journal.Pone.0034262 |
0.385 |
|
| 2012 |
Xiao Y, Decker PA, Rice T, McCoy LS, Smirnov I, Patoka JS, Hansen HM, Wiemels JL, Tihan T, Prados MD, Chang SM, Berger MS, Kosel ML, Fridley BL, Lachance DH, et al. SSBP2 variants are associated with survival in glioblastoma patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 18: 3154-62. PMID 22472174 DOI: 10.1158/1078-0432.Ccr-11-2778 |
0.437 |
|
| 2012 |
Kelemen LE, Wang Q, Dinu I, Vierkant RA, Tsai YY, Cunningham JM, Phelan CM, Fridley BL, Amankwah EK, Iversen ES, Berchuck A, Schildkraut JM, Goode EL, Sellers TA. Regular Multivitamin Supplement Use, Single Nucleotide Polymorphisms in ATIC, SHMT2, and SLC46A1, and Risk of Ovarian Carcinoma. Frontiers in Genetics. 3: 33. PMID 22461784 DOI: 10.3389/Fgene.2012.00033 |
0.438 |
|
| 2012 |
Fridley BL, Lund S, Jenkins GD, Wang L. A Bayesian integrative genomic model for pathway analysis of complex traits. Genetic Epidemiology. 36: 352-9. PMID 22460780 DOI: 10.1002/Gepi.21628 |
0.331 |
|
| 2012 |
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, ... ... Fridley BL, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. The Lancet. Oncology. 13: 385-94. PMID 22361336 DOI: 10.1016/S1470-2045(11)70404-1 |
0.437 |
|
| 2012 |
Abo R, Hebbring S, Ji Y, Zhu H, Zeng ZB, Batzler A, Jenkins GD, Biernacka J, Snyder K, Drews M, Fiehn O, Fridley B, Schaid D, Kamatani N, Nakamura Y, et al. Merging pharmacometabolomics with pharmacogenomics using '1000 Genomes' single-nucleotide polymorphism imputation: selective serotonin reuptake inhibitor response pharmacogenomics. Pharmacogenetics and Genomics. 22: 247-53. PMID 22322242 DOI: 10.1097/Fpc.0B013E32835001C9 |
0.4 |
|
| 2012 |
Fridley BL, Jenkins GD, Tsai YY, Song H, Bolton KL, Fenstermacher D, Tyrer J, Ramus SJ, Cunningham JM, Vierkant RA, Chen Z, Chen YA, Iversen E, Menon U, Gentry-Maharaj A, et al. Gene set analysis of survival following ovarian cancer implicates macrolide binding and intracellular signaling genes. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 529-36. PMID 22302016 DOI: 10.1158/1055-9965.Epi-11-0741 |
0.502 |
|
| 2012 |
White KL, Schildkraut JM, Palmieri RT, Iversen ES, Berchuck A, Vierkant RA, Rider DN, Charbonneau B, Cicek MS, Sutphen R, Birrer MJ, Pharoah PP, Song H, Tyrer J, Gayther SA, ... ... Fridley BL, et al. Ovarian cancer risk associated with inherited inflammation-related variants. Cancer Research. 72: 1064-9. PMID 22282663 DOI: 10.1158/0008-5472.Can-11-3512 |
0.532 |
|
| 2012 |
Bolton KL, Chenevix-Trench G, Goh C, Sadetzki S, Ramus SJ, Karlan BY, Lambrechts D, Despierre E, Barrowdale D, McGuffog L, Healey S, Easton DF, Sinilnikova O, BenÃtez J, GarcÃa MJ, ... ... Fridley BL, et al. Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. Jama. 307: 382-90. PMID 22274685 DOI: 10.1001/Jama.2012.20 |
0.373 |
|
| 2012 |
Stevens KN, Kelemen LE, Wang X, Fridley BL, Vierkant RA, Fredericksen Z, Armasu SM, Tsai YY, Berchuck A, Narod SA, Phelan CM, Sutphen R, Birrer MJ, Schildkraut JM, Sellers TA, et al. Common variation in Nemo-like kinase is associated with risk of ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 21: 523-8. PMID 22253297 DOI: 10.1158/1055-9965.Epi-11-0797 |
0.508 |
|
| 2012 |
Hebbring SJ, Chai Y, Ji Y, Abo RP, Jenkins GD, Fridley B, Zhang J, Eckloff BW, Wieben ED, Weinshilboum RM. Serine hydroxymethyltransferase 1 and 2: gene sequence variation and functional genomic characterization. Journal of Neurochemistry. 120: 881-90. PMID 22220685 DOI: 10.1111/J.1471-4159.2012.07646.X |
0.417 |
|
| 2012 |
Li L, Schaid DJ, Fridley BL, Kalari KR, Jenkins GD, Abo RP, Batzler A, Moon I, Pelleymounter L, Eckloff BW, Wieben ED, Sun Z, Yang P, Wang L. Gemcitabine metabolic pathway genetic polymorphisms and response in patients with non-small cell lung cancer. Pharmacogenetics and Genomics. 22: 105-16. PMID 22173087 DOI: 10.1097/Fpc.0B013E32834Dd7E2 |
0.41 |
|
| 2012 |
Biernacka JM, Jenkins GD, Wang L, Moyer AM, Fridley BL. Use of the gamma method for self-contained gene-set analysis of SNP data. European Journal of Human Genetics : Ejhg. 20: 565-71. PMID 22166939 DOI: 10.1038/Ejhg.2011.236 |
0.426 |
|
| 2012 |
Chalise P, Fridley BL. Comparison of Penalty Functions for Sparse Canonical Correlation Analysis. Computational Statistics & Data Analysis. 56: 245-254. PMID 21984855 DOI: 10.1016/J.Csda.2011.07.012 |
0.305 |
|
| 2012 |
Laurie CC, Laurie CA, Fridley B, Carlson E, Smoley SA, Flinn IW, Tallman MS, Paietta E, Weinshilboum R, Kay NE, Shanafelt TD. Clonal Chromosomal Anomalies Similar to CLL and Other Hematologic Malignancies Can Be Found in “Normal” Individuals Blood. 120: 873-873. DOI: 10.1182/Blood.V120.21.873.873 |
0.329 |
|
| 2012 |
Olson JE, Cicek MS, Fridley BL, Armasu SM, Larson MC, Vierkant RA, Rider DL, Kalli KR, Cunningham JM, Goode EL. Abstract 5008: Genome-wide methylation and ovarian cancer survival Cancer Research. 72: 5008-5008. DOI: 10.1158/1538-7445.Am2012-5008 |
0.457 |
|
| 2012 |
Permuth-Wey J, Lin H, Tsai Y, Zhihua C, Chen YA, Barnholtz-Sloan J, Birrer MJ, Chanock S, Cramer DW, Cunningham JM, Fenstermacher D, Fridley B, Garcia-Closas M, Gayther SA, Gentry-Maharaj A, et al. Abstract 2927: MicroRNA binding site polymorphisms influence ovarian cancer risk in the collaborative oncological gene-environment study Cancer Research. 72: 2927-2927. DOI: 10.1158/1538-7445.Am2012-2927 |
0.447 |
|
| 2012 |
Cicek MS, Fridley BL, Rumilla KM, Lindor NM, Block MS, Song H, Pharoah P, Sellers TA, Goode EL. Abstract 2619: Relevance of mismatch repair deficiency in ovarian cancer Cancer Research. 72: 2619-2619. DOI: 10.1158/1538-7445.Am2012-2619 |
0.46 |
|
| 2012 |
Charbonneau B, White KL, Schildkraut JM, Palmieri RT, Iversen E, Berchuck A, Vierkant RA, Rider DN, Cicek MS, Sutphen R, Birrer MJ, Pharoah PPD, Song H, Tyrer J, Gayther SA, ... ... Fridley BL, et al. Abstract 2603: Subtype-specific ovarian cancer risk associated with SNPs inIL1A: Cancer Research. 72: 2603-2603. DOI: 10.1158/1538-7445.Am2012-2603 |
0.493 |
|
| 2012 |
Raska P, Iversen ES, Chen A, Chen Z, Fridley BL, Permuth-Wey J, Tsai Y, Vierkant RA, Goode EL, Risch H, Schildkraut JM, Sellers TA, Barnholtz-Sloan J. Abstract 1678: European ancestry and ovarian cancer: Testing for their association using case control data Cancer Research. 72: 1678-1678. DOI: 10.1158/1538-7445.Am2012-1678 |
0.375 |
|
| 2012 |
Tsai Y, Monteiro ANA, Phelan CM, Iversen E, Fridley BL, Chen YA, Chen Z, Permuth-Wey J, Jim HS, Vierkant RA, Cunningham JM, Barnholtz-Sloan J, August A, Sutphen R, Narod S, et al. Abstract 1649: Genome-wide association study of copy number variations in serous epithelial ovarian cancer susceptibility Cancer Research. 72: 1649-1649. DOI: 10.1158/1538-7445.Am2012-1649 |
0.488 |
|
| 2012 |
Fridley BL. Abstract IA05: Integrative approaches for understanding the functional relevance of cancer susceptibility loci. Cancer Epidemiology Biomarkers & Prevention. 21: IA05-IA05. DOI: 10.1158/1055-9965.Gwas-Ia05 |
0.471 |
|
| 2011 |
Ingle JN, Fridley BL, Buzdar A, Robson ME, Kubo M, Liu M, Ibrahim-Zada I, Batzler A, Jenkins GD, Goetz MP, Northfelt DW, Perez EA, Williard CV, Wang L, Schaid DJ, et al. Genes regulating estradiol and estrone-conjugate levels in postmenopausal women with resected early-stage breast cancer detected by a genome-wide association study (GWAS). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 29: 1001. PMID 28020772 DOI: 10.1200/Jco.2011.29.15_Suppl.1001 |
0.35 |
|
| 2011 |
Brisbin AG, Asmann YW, Song H, Tsai YY, Aakre JA, Yang P, Jenkins RB, Pharoah P, Schumacher F, Conti DV, Duggan DJ, Jenkins M, Hopper J, Gallinger S, Newcomb P, ... ... Fridley BL, et al. Meta-analysis of 8q24 for seven cancers reveals a locus between NOV and ENPP2 associated with cancer development. Bmc Medical Genetics. 12: 156. PMID 22142333 DOI: 10.1186/1471-2350-12-156 |
0.459 |
|
| 2011 |
Arruda-Olson AM, Roger VL, Chai HS, de Andrade M, Fridley BL, Cunningham JM, Gabriel SE, Bielinski SJ. Association of TNFSF8 polymorphisms with peripheral neutrophil count. Mayo Clinic Proceedings. 86: 1075-81. PMID 22033252 DOI: 10.4065/Mcp.2011.0275 |
0.388 |
|
| 2011 |
Beesley J, Pickett HA, Johnatty SE, Dunning AM, Chen X, Li J, Michailidou K, Lu Y, Rider DN, Palmieri RT, Stutz MD, Lambrechts D, Despierre E, Lambrechts S, Vergote I, ... ... Fridley BL, et al. Functional polymorphisms in the TERT promoter are associated with risk of serous epithelial ovarian and breast cancers. Plos One. 6: e24987. PMID 21949822 DOI: 10.1371/Journal.Pone.0024987 |
0.496 |
|
| 2011 |
Fridley BL, Batzler A, Li L, Li F, Matimba A, Jenkins GD, Ji Y, Wang L, Weinshilboum RM. Gene set analysis of purine and pyrimidine antimetabolites cancer therapies. Pharmacogenetics and Genomics. 21: 701-12. PMID 21869733 DOI: 10.1097/Fpc.0B013E32834A48A9 |
0.347 |
|
| 2011 |
Tan XL, Moyer AM, Fridley BL, Schaid DJ, Niu N, Batzler AJ, Jenkins GD, Abo RP, Li L, Cunningham JM, Sun Z, Yang P, Wang L. Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinum-based chemotherapy. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5801-11. PMID 21775533 DOI: 10.1158/1078-0432.Ccr-11-1133 |
0.463 |
|
| 2011 |
Lachance DH, Yang P, Johnson DR, Decker PA, Kollmeyer TM, McCoy LS, Rice T, Xiao Y, Ali-Osman F, Wang F, Stoddard SM, Sprau DJ, Kosel ML, Wiencke JK, Wiemels JL, ... ... Fridley BL, et al. Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking. American Journal of Epidemiology. 174: 574-81. PMID 21742680 DOI: 10.1093/Aje/Kwr124 |
0.323 |
|
| 2011 |
Goode EL, Chenevix-Trench G, Hartmann LC, Fridley BL, Kalli KR, Vierkant RA, Larson MC, White KL, Keeney GL, Oberg TN, Cunningham JM, Beesley J, Johnatty SE, Chen X, Goodman KE, et al. Assessment of hepatocyte growth factor in ovarian cancer mortality. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1638-48. PMID 21724856 DOI: 10.1158/1055-9965.Epi-11-0455 |
0.366 |
|
| 2011 |
Huang RS, Johnatty SE, Gamazon ER, Im HK, Ziliak D, Duan S, Zhang W, Kistner EO, Chen P, Beesley J, Mi S, O'Donnell PH, Fraiman YS, Das S, Cox NJ, ... ... Fridley BL, et al. Platinum sensitivity-related germline polymorphism discovered via a cell-based approach and analysis of its association with outcome in ovarian cancer patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 5490-500. PMID 21705454 DOI: 10.1158/1078-0432.Ccr-11-0724 |
0.421 |
|
| 2011 |
Fridley BL, Iversen E, Tsai YY, Jenkins GD, Goode EL, Sellers TA. A latent model for prioritization of SNPs for functional studies. Plos One. 6: e20764. PMID 21687685 DOI: 10.1371/Journal.Pone.0020764 |
0.453 |
|
| 2011 |
Peethambaram P, Fridley BL, Vierkant RA, Larson MC, Kalli KR, Elliott EA, Oberg AL, White KL, Rider DN, Keeney GL, Cunningham JM, Hartmann LC, Goode EL. Polymorphisms in ABCB1 and ERCC2 associated with ovarian cancer outcome. International Journal of Molecular Epidemiology and Genetics. 2: 185-95. PMID 21686133 |
0.397 |
|
| 2011 |
Amankwah EK, Wang Q, Schildkraut JM, Tsai YY, Ramus SJ, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Dale LC, Lambrechts D, Amant F, Despierre E, et al. Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium. Plos One. 6: e19642. PMID 21637745 DOI: 10.1371/Journal.Pone.0019642 |
0.47 |
|
| 2011 |
Permuth-Wey J, Chen Z, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Chanock SJ, Cramer DW, Cunningham JM, Fenstermacher D, Fridley BL, Garcia-Closas M, Gayther SA, Gentry-Maharaj A, et al. MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1793-7. PMID 21636674 DOI: 10.1158/1055-9965.Epi-11-0397 |
0.496 |
|
| 2011 |
Fridley BL, Biernacka JM. Gene set analysis of SNP data: Benefits, challenges, and future directions European Journal of Human Genetics. 19: 837-843. PMID 21487444 DOI: 10.1038/Ejhg.2011.57 |
0.425 |
|
| 2011 |
Permuth-Wey J, Kim D, Tsai YY, Lin HY, Chen YA, Barnholtz-Sloan J, Birrer MJ, Bloom G, Chanock SJ, Chen Z, Cramer DW, Cunningham JM, Dagne G, Ebbert-Syfrett J, Fenstermacher D, ... Fridley BL, et al. LIN28B polymorphisms influence susceptibility to epithelial ovarian cancer. Cancer Research. 71: 3896-903. PMID 21482675 DOI: 10.1158/0008-5472.Can-10-4167 |
0.467 |
|
| 2011 |
Goode EL, White KL, Vierkant RA, Phelan CM, Cunningham JM, Schildkraut JM, Berchuck A, Larson MC, Fridley BL, Olson JE, Webb PM, Chen X, Beesley J, Chenevix-Trench G, Sellers TA, et al. Xenobiotic-Metabolizing gene polymorphisms and ovarian cancer risk. Molecular Carcinogenesis. 50: 397-402. PMID 21480392 DOI: 10.1002/Mc.20714 |
0.502 |
|
| 2011 |
Reid-Lombardo KM, Fridley BL, Bamlet WR, Cunningham JM, Sarr MG, Petersen GM. Inflammation-related gene variants as risk factors for pancreatic cancer Cancer Epidemiology Biomarkers and Prevention. 20: 1251-1254. PMID 21467233 DOI: 10.1158/1055-9965.Epi-11-0264 |
0.447 |
|
| 2011 |
Permuth-Wey J, Chen YA, Tsai YY, Chen Z, Qu X, Lancaster JM, Stockwell H, Dagne G, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Sutphen R, et al. Inherited variants in mitochondrial biogenesis genes may influence epithelial ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1131-45. PMID 21447778 DOI: 10.1158/1055-9965.Epi-10-1224 |
0.396 |
|
| 2011 |
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, ... ... Fridley BL, et al. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1028-31. PMID 21415361 DOI: 10.1158/1055-9965.Epi-11-0053 |
0.461 |
|
| 2011 |
Wu TY, Fridley BL, Jenkins GD, Batzler A, Wang L, Weinshilboum RM. Mycophenolic acid response biomarkers: a cell line model system-based genome-wide screen. International Immunopharmacology. 11: 1057-64. PMID 21396482 DOI: 10.1016/J.Intimp.2011.02.027 |
0.376 |
|
| 2011 |
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Fridley BL, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 |
0.48 |
|
| 2011 |
Jenkins RB, Wrensch MR, Johnson D, Fridley BL, Decker PA, Xiao Y, Kollmeyer TM, Rynearson AL, Fink S, Rice T, McCoy LS, Halder C, Kosel ML, Giannini C, Tihan T, et al. Distinct germ line polymorphisms underlie glioma morphologic heterogeneity. Cancer Genetics. 204: 13-8. PMID 21356187 DOI: 10.1016/J.Cancergencyto.2010.10.002 |
0.414 |
|
| 2011 |
Moyer AM, Fridley BL, Jenkins GD, Batzler AJ, Pelleymounter LL, Kalari KR, Ji Y, Chai Y, Nordgren KK, Weinshilboum RM. Acetaminophen-NAPQI hepatotoxicity: a cell line model system genome-wide association study. Toxicological Sciences : An Official Journal of the Society of Toxicology. 120: 33-41. PMID 21177773 DOI: 10.1093/Toxsci/Kfq375 |
0.44 |
|
| 2011 |
Feng Q, Kalari K, Fridley BL, Jenkins G, Ji Y, Abo R, Hebbring S, Zhang J, Nye MD, Leeder JS, Weinshilboum RM. Betaine-homocysteine methyltransferase: human liver genotype-phenotype correlation. Molecular Genetics and Metabolism. 102: 126-33. PMID 21093336 DOI: 10.1016/J.Ymgme.2010.10.010 |
0.377 |
|
| 2011 |
Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, Kjær SK, Hogdall E, Gayther SA, et al. Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertility and Sterility. 95: 40-5. PMID 20719308 DOI: 10.1016/J.Fertnstert.2010.06.059 |
0.381 |
|
| 2011 |
Vierkant RA, Kalli KR, White KL, Larson MC, Fridley BL, Keeney GL, Oberg TN, Phelan CM, Sellers TA, Cunningham JM, Goode EL. Abstract 893: Associations between HGF, MET, and phospho-MET expression, overall survival, and HGF genotypes in epithelial ovarian cancer Cancer Research. 71: 893-893. DOI: 10.1158/1538-7445.Am2011-893 |
0.473 |
|
| 2011 |
Cicek MS, Armasu SM, Kalli KR, Fridley BL, Sellers TA, Tsai Y, Cunningham JM, Goode EL. Abstract 5616: Assessment of differential DNA methylation by genotype in ovarian cancer cases and controls Cancer Research. 71: 5616-5616. DOI: 10.1158/1538-7445.Am2011-5616 |
0.459 |
|
| 2011 |
Chen YA, Chen Z, Tsai Y, Qu X, Iversen E, Barnholtz-Sloan J, Fridley BL, Permuth-Wey J, Risch H, Cunningham JM, Vierkant RA, Fenstermacher D, Sutphen R, Phelan CM, Monteiro AN, et al. Abstract 4729: Pathway and gene set analyses for epithelial ovarian cancer (EOC) genome-wide association study (GWAS) Cancer Research. 71: 4729-4729. DOI: 10.1158/1538-7445.Am2011-4729 |
0.499 |
|
| 2011 |
MacGregor S, Lu Y, Johnatty S, Beesley J, Chen XQ, Fridley B, Webb P, Gurney H, Harnett P, Haber M, Goode E, Fazio AD, Chenevix-Trench G. Abstract 4679: A multi-stage genome-wide association study on response to chemotherapy in ovarian cancer Cancer Research. 71: 4679-4679. DOI: 10.1158/1538-7445.Am2011-4679 |
0.51 |
|
| 2011 |
Fridley BL, Jenkins GD, Tsai Y, Fenstermacher D, Schildkraut J, Sutphen R, Chen YA, Iversen E, Vierkant RA, Cunningham JM, Chen Z, Sellers TA, Goode EL. Abstract 2738: Insights into survival from ovarian cancer revealed by gene set analysis Epidemiology. 71: 2738-2738. DOI: 10.1158/1538-7445.Am2011-2738 |
0.424 |
|
| 2011 |
Ibrahim-zada I, Ingle JN, Fridley BL, Buzdar A, Robson ME, Kubo M, Batzler A, Jenkins GD, Goetz MP, Northfelt DW, Perez EA, Williard CV, Wang L, Schaid DJ, Nakamura Y, et al. Abstract C114: Androstenedione levels in postmenopausal women with resected early-stage breast cancer are associated with SNPs in CYP11B1 and CYP11B2 identified by a genome-wide association study (GWAS). Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-C114 |
0.457 |
|
| 2010 |
Niu N, Qin Y, Fridley BL, Hou J, Kalari KR, Zhu M, Wu TY, Jenkins GD, Batzler A, Wang L. Radiation pharmacogenomics: a genome-wide association approach to identify radiation response biomarkers using human lymphoblastoid cell lines. Genome Research. 20: 1482-92. PMID 20923822 DOI: 10.1101/Gr.107672.110 |
0.396 |
|
| 2010 |
Fridley BL, Jenkins GD, Biernacka JM. Self-Contained gene-set analysis of expression data: An evaluation of existing and novel methods Plos One. 5: 1-9. PMID 20862301 DOI: 10.1371/Journal.Pone.0012693 |
0.346 |
|
| 2010 |
Li F, Fridley BL, Matimba A, Kalari KR, Pelleymounter L, Moon I, Ji Y, Jenkins GD, Batzler A, Wang L, Weinshilboum RM. Ecto-5'-nucleotidase and thiopurine cellular circulation: association with cytotoxicity. Drug Metabolism and Disposition: the Biological Fate of Chemicals. 38: 2329-38. PMID 20855458 DOI: 10.1124/Dmd.110.035220 |
0.408 |
|
| 2010 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, ... ... Fridley BL, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666 |
0.501 |
|
| 2010 |
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Fridley BL, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668 |
0.482 |
|
| 2010 |
Fridley BL, Serie D, Jenkins G, White K, Bamlet W, Potter JD, Goode EL. Bayesian mixture models for the incorporation of prior knowledge to inform genetic association studies. Genetic Epidemiology. 34: 418-26. PMID 20583285 DOI: 10.1002/Gepi.20494 |
0.372 |
|
| 2010 |
Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G, ... ... Fridley BL, et al. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1822-30. PMID 20570913 DOI: 10.1158/1055-9965.Epi-09-1317 |
0.425 |
|
| 2010 |
Fridley BL, Jenkins GD. Localizing putative markers in genetic association studies by incorporating linkage disequilibrium into bayesian hierarchical models Human Heredity. 70: 63-73. PMID 20551675 DOI: 10.1159/000313852 |
0.386 |
|
| 2010 |
Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, Jenkins R, Le Marchand L, Casey G, et al. Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Research. 70: 5409-18. PMID 20551049 DOI: 10.1158/0008-5472.Can-10-0188 |
0.46 |
|
| 2010 |
Fridley BL, Jenkins G, Deyo-Svendsen ME, Hebbring S, Freimuth R. Utilizing genotype imputation for the augmentation of sequence data Plos One. 5. PMID 20543988 DOI: 10.1371/Journal.Pone.0011018 |
0.413 |
|
| 2010 |
White KL, Sellers TA, Fridley BL, Vierkant RA, Phelan CM, Tsai YY, Kalli KR, Berchuck A, Iversen ES, Hartmann LC, Liebow M, Armasu S, Fredericksen Z, Larson MC, Duggan D, et al. Variation at 8q24 and 9p24 and risk of epithelial ovarian cancer. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 13: 43-56. PMID 20158306 DOI: 10.1375/Twin.13.1.43 |
0.463 |
|
| 2010 |
Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861 |
0.524 |
|
| 2010 |
Peedicayil A, Vierkant RA, Hartmann LC, Fridley BL, Fredericksen ZS, White KL, Elliott EA, Phelan CM, Tsai YY, Berchuck A, Iversen ES, Couch FJ, Peethamabaran P, Larson MC, Kalli KR, et al. Risk of ovarian cancer and inherited variants in relapse-associated genes. Plos One. 5: e8884. PMID 20111712 DOI: 10.1371/Journal.Pone.0008884 |
0.479 |
|
| 2010 |
Goode EL, Maurer MJ, Sellers TA, Phelan CM, Kalli KR, Fridley BL, Vierkant RA, Armasu SM, White KL, Keeney GL, Cliby WA, Rider DN, Kelemen LE, Jones MB, Peethambaram PP, et al. Inherited determinants of ovarian cancer survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 16: 995-1007. PMID 20103664 DOI: 10.1158/1078-0432.Ccr-09-2553 |
0.447 |
|
| 2010 |
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, ... ... Fridley BL, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 245-50. PMID 20056644 DOI: 10.1158/1055-9965.Epi-09-0729 |
0.502 |
|
| 2010 |
Wang L, Ellsworth KA, Moon I, Pelleymounter LL, Eckloff BW, Martin YN, Fridley BL, Jenkins GD, Batzler A, Suman VJ, Ravi S, Dixon JM, Miller WR, Wieben ED, Buzdar A, et al. Functional genetic polymorphisms in the aromatase gene CYP19 vary the response of breast cancer patients to neoadjuvant therapy with aromatase inhibitors. Cancer Research. 70: 319-28. PMID 20048079 DOI: 10.1158/0008-5472.Can-09-3224 |
0.458 |
|
| 2010 |
White KL, Sellers TA, Vierkant RA, Phelan C, Cunningham JM, Schildkraut JM, Berchuck A, Fridley BL, Olson JE, Beesley J, Chenevix-Trench G, Goode EL. Abstract 914: Xenobiotic metabolizing SNPs and ovarian cancer risk Cancer Research. 70: 914-914. DOI: 10.1158/1538-7445.Am10-914 |
0.51 |
|
| 2010 |
Cunningham JM, Hartmann LC, Fridley BL, Armasu SM, Vierkant RA, Sicotte H, Tsai Y, Phelan CM, White KL, Sutphen R, Kellemen LE, Kalli KR, Keeney GL, Schildtkraut JM, Couch FJ, et al. Abstract 897: Association of inherited variants in HGF and ovarian cancer survival time Cancer Research. 70: 897-897. DOI: 10.1158/1538-7445.Am10-897 |
0.515 |
|
| 2010 |
Fridley BL, Jenkins G, Deyo-Svendsen M, Hebbring S, Freimuth R. Abstract 4738: Utilizing genotype imputation for the augmentation of sequence data Cancer Research. 70: 4738-4738. DOI: 10.1158/1538-7445.Am10-4738 |
0.41 |
|
| 2010 |
Tsai Y, Chen YA, Chen Z, Permuth-Wey J, Iversen E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Fenstermacher D, Sutphen R, Phelan CM, Narod SA, Schildkraut JM, et al. Abstract 4724: A novel region on 8q24.21 is associated with ovarian cancer susceptibility Cancer Research. 70: 4724-4724. DOI: 10.1158/1538-7445.Am10-4724 |
0.517 |
|
| 2010 |
Peedicayil A, Vierkant RA, Hartmann LC, Fridley BL, Fredericksen ZS, White KL, Elliott EA, Phelan CM, Tsai Y, Berchuck A, Iversen ES, Couch FJ, Peethambaram PP, Larson MC, Kalli KR, et al. Abstract 4718: Inherited variants in relapse-associated genes and risk of ovarian cancer Cancer Research. 70: 4718-4718. DOI: 10.1158/1538-7445.Am10-4718 |
0.525 |
|
| 2010 |
Hou J, Niu N, Qin Y, Fridley BL, Kalari K, Jenkins G, Batzler A, Wang L. Abstract 3602: Radiation pharmacogenomics: an integrative analysis approach to identify biomarkers using the human lymphoblastoid cell lines Cancer Research. 70: 3602-3602. DOI: 10.1158/1538-7445.Am10-3602 |
0.423 |
|
| 2010 |
Amankwah EK, Wang Q, Tsai Y, Fridley BL, Beesley J, Johnatty SE, Webb PM, Chenevix-Trench G, Phelan CM, Cunningham JM, Vachon CM, Vierkant RA, Iversen ES, Berchuck A, Schildkraut JM, et al. Abstract 2854: Genetic variation in stromal genes decorin and lumican and susceptibility to serous ovarian cancer Cancer Research. 70: 2854-2854. DOI: 10.1158/1538-7445.Am10-2854 |
0.476 |
|
| 2010 |
Permuth-Wey J, Tsai Y, Chen YA, Chen Z, Lancaster JM, Iverson E, Risch H, Barnholtz-Sloan J, Cunningham JM, Vierkant RA, Fridley BL, Fenstermacher D, Sutphen R, Narod SA, Goode EL, et al. Abstract 2835: Mitochondrial genetic variants influence ovarian cancer risk Cancer Research. 70: 2835-2835. DOI: 10.1158/1538-7445.Am10-2835 |
0.494 |
|
| 2010 |
Niu N, Fridley BL, Kalari KR, Jenkins GD, Anthony B, Wang L. Abstract 2599: Taxane pharmacogenomics: Identifying genetic variation associated with drug cytotoxicity using a genome-wide association approach and a cell line model system Cancer Research. 70: 2599-2599. DOI: 10.1158/1538-7445.Am10-2599 |
0.47 |
|
| 2010 |
Lombardo KR, Fridley BL, Cunningham JM, Sarr MG, Petersen GM. M2057 Inflammatory-Related Gene Variants as Risk Factors for Pancreatic Cancer: Does NOS Play a Role? Gastroenterology. 138: S-881. DOI: 10.1016/S0016-5085(10)64068-1 |
0.369 |
|
| 2009 |
Fridley BL, McDonnell SK, Rabe KG, Tang R, Biernacka JM, Sinnwell JP, Rider DN, Goode EL. Single versus multiple imputation for genotypic data. Bmc Proceedings. 3: S7. PMID 20018064 DOI: 10.1186/1753-6561-3-S7-S7 |
0.373 |
|
| 2009 |
Biernacka JM, Tang R, Li J, McDonnell SK, Rabe KG, Sinnwell JP, Rider DN, de Andrade M, Goode EL, Fridley BL. Assessment of genotype imputation methods. Bmc Proceedings. 3: S5. PMID 20018042 DOI: 10.1186/1753-6561-3-S7-S5 |
0.399 |
|
| 2009 |
Li L, Fridley BL, Kalari K, Jenkins G, Batzler A, Weinshilboum RM, Wang L. Gemcitabine and arabinosylcytosin pharmacogenomics: genome-wide association and drug response biomarkers. Plos One. 4: e7765. PMID 19898621 DOI: 10.1371/Journal.Pone.0007765 |
0.453 |
|
| 2009 |
Cunningham JM, Vierkant RA, Sellers TA, Phelan C, Rider DN, Liebow M, Schildkraut J, Berchuck A, Couch FJ, Wang X, Fridley BL, Gentry-Maharaj A, Menon U, Hogdall E, et al. Cell cycle genes and ovarian cancer susceptibility: a tagSNP analysis. British Journal of Cancer. 101: 1461-8. PMID 19738611 DOI: 10.1038/Sj.Bjc.6605284 |
0.419 |
|
| 2009 |
Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, Lingle W, Petersen G, Lou Z, Wang L. FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell. 16: 259-66. PMID 19732725 DOI: 10.1016/J.Ccr.2009.07.016 |
0.363 |
|
| 2009 |
Goode EL, Szabo C, Prokunina-Olsson L, Vierkant RA, Fredericksen ZS, Collins FS, White KL, Schmidt M, Fridley BL, Couch FJ. No association between a candidate TCF7L2 variant and risk of breast or ovarian cancer. Bmc Cancer. 9: 312. PMID 19732438 DOI: 10.1186/1471-2407-9-312 |
0.422 |
|
| 2009 |
Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, ... ... Fridley BL, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424 |
0.516 |
|
| 2009 |
Fridley BL, Jenkins G, Schaid DJ, Wang L. A Bayesian hierarchical nonlinear model for assessing the association between genetic variation and drug cytotoxicity. Statistics in Medicine. 28: 2709-22. PMID 19572260 DOI: 10.1002/Sim.3649 |
0.315 |
|
| 2009 |
White KL, Vierkant RA, Phelan CM, Fridley BL, Anderson S, Knutson KL, Schildkraut JM, Cunningham JM, Kelemen LE, Pankratz VS, Rider DN, Liebow M, Hartmann LC, Sellers TA, Goode EL. Polymorphisms in NF-kappaB inhibitors and risk of epithelial ovarian cancer. Bmc Cancer. 9: 170. PMID 19500386 DOI: 10.1186/1471-2407-9-170 |
0.318 |
|
| 2009 |
Peedicayil A, Vierkant RA, Shridhar V, Schildkraut JM, Armasu S, Hartmann LC, Fridley BL, Cunningham JM, Phelan CM, Sellers TA, Goode EL. Polymorphisms in TCEAL7 and risk of epithelial ovarian cancer Gynecologic Oncology. 114: 260-264. PMID 19419758 DOI: 10.1016/J.Ygyno.2009.03.038 |
0.521 |
|
| 2009 |
Goode EL, Fridley BL, Vierkant RA, Cunningham JM, Phelan CM, Anderson S, Rider DN, White KL, Pankratz VS, Song H, Hogdall E, Kjaer SK, Whittemore AS, DiCioccio R, Ramus SJ, et al. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 935-44. PMID 19258477 DOI: 10.1158/1055-9965.Epi-08-0860 |
0.472 |
|
| 2009 |
Park KH, Fridley BL, Ryu E, Tosakulwong N, Edwards AO. Complement component 3 (C3) haplotypes and risk of advanced age-related macular degeneration Investigative Ophthalmology and Visual Science. 50: 3386-3393. PMID 19234341 DOI: 10.1167/Iovs.08-3231 |
0.384 |
|
| 2009 |
Srinivasan BS, Chen J, Cheng C, Conti D, Duan S, Fridley BL, Gu X, Haines JL, Jorgenson E, Kraja A, Lasky-Su J, Li L, Rodin A, Wang D, Province M, et al. Methods for analysis in pharmacogenomics: lessons from the Pharmacogenetics Research Network Analysis Group. Pharmacogenomics. 10: 243-51. PMID 19207025 DOI: 10.2217/14622416.10.2.243 |
0.364 |
|
| 2009 |
Fridley BL. Bayesian Variable and model selection methods for genetic association studies Genetic Epidemiology. 33: 27-37. PMID 18618760 DOI: 10.1002/Gepi.20353 |
0.417 |
|
| 2008 |
Edwards AO, Fridley BL, James KM, Sharma AS, Cunningham JM, Tosakulwong N. Evaluation of clustering and genotype distribution for replication in genome wide association studies: The age-related eye disease study Plos One. 3. PMID 19043567 DOI: 10.1371/Journal.Pone.0003813 |
0.424 |
|
| 2008 |
Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Lazaridis KN. Primary Biliary Cirrhosis Is Associated With a Genetic Variant in the 3′ Flanking Region of the CTLA4 Gene Gastroenterology. 135: 1200-1206. PMID 18778710 DOI: 10.1053/J.Gastro.2008.06.077 |
0.431 |
|
| 2008 |
Li L, Fridley B, Kalari K, Jenkins G, Batzler A, Safgren S, Hildebrandt M, Ames M, Schaid D, Wang L. Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression. Cancer Research. 68: 7050-8. PMID 18757419 DOI: 10.1158/0008-5472.Can-08-0405 |
0.38 |
|
| 2008 |
Turner ST, Bailey KR, Fridley BL, Chapman AB, Schwartz GL, Chai HS, Sicotte H, Kocher JP, Rodin AS, Boerwinkle E. Genomic association analysis suggests chromosome 12 locus influencing antihypertensive response to thiazide diuretic. Hypertension. 52: 359-65. PMID 18591461 DOI: 10.1161/Hypertensionaha.107.104273 |
0.398 |
|
| 2008 |
Edwards AO, Lee SJ, Fridley BL, Tosakulwong N. Density of common complex ocular traits in the aging eye: Analysis of secondary traits in genome-wide association studies Plos One. 3. PMID 18575587 DOI: 10.1371/Journal.Pone.0002510 |
0.318 |
|
| 2008 |
Ji Y, Snyder EM, Fridley BL, Salavaggione OE, Moon I, Batzler A, Yee VC, Schaid DJ, Joyner MJ, Johnson BD, Weinshilboum RM. Human phenylethanolamine N-methyltransferase genetic polymorphisms and exercise-induced epinephrine release. Physiological Genomics. 33: 323-32. PMID 18349382 DOI: 10.1152/Physiolgenomics.00248.2007 |
0.38 |
|
| 2008 |
Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB. Genetic regulation of beta-ureidopropionase and its possible implication in altered uracil catabolism. Pharmacogenetics and Genomics. 18: 25-35. PMID 18216719 DOI: 10.1097/Fpc.0B013E3282F2F134 |
0.309 |
|
| 2008 |
Juran BD, Atkinson EJ, Schlicht EM, Fridley BL, Petersen GM, Lazaridis KN. Interacting alleles of the coinhibitory immunoreceptor genes cytotoxic T-lymphocyte antigen 4 and programmed cell-death 1 influence risk and features of primary biliary cirrhosis Hepatology. 47: 563-570. PMID 18041714 DOI: 10.1002/Hep.22048 |
0.407 |
|
| 2008 |
Pardanani A, Fridley BL, Lasho TL, Gilliland DG, Tefferi A. Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders Blood. 111: 2785-2789. PMID 18006699 DOI: 10.1182/Blood-2007-06-095703 |
0.413 |
|
| 2008 |
Fridley BL, Turner ST, Chapman AB, Rodin AS, Boerwinkle E, Bailey KR. Reproducibility of genotypes as measured by the affymetrix GeneChip® 100K Human Mapping Array set Computational Statistics and Data Analysis. 52: 5367-5374. DOI: 10.1016/J.Csda.2008.05.020 |
0.371 |
|
| 2007 |
Atkinson EJ, Fridley BL, Goode EL, McDonnell SK, Liu-Mares W, Rabe KG, Sun Z, Slager SL, de Andrade M. Linkage analysis using principal components of gene expression data. Bmc Proceedings. S79. PMID 18466581 DOI: 10.1186/1753-6561-1-S1-S79 |
0.322 |
|
| 2007 |
Goode EL, Fridley BL, Sun Z, Atkinson EJ, Nord AS, McDonnell SK, Jarvik GP, de Andrade M, Slager SL. Comparison of tagging single-nucleotide polymorphism methods in association analyses. Bmc Proceedings. 1: S6. PMID 18466560 DOI: 10.1186/1753-6561-1-S1-S6 |
0.412 |
|
| 2007 |
Ye Z, Atkinson EJ, Fridley BL, de Andrade M. Comparison of variable and model selection methods for genetic association studies using the GAW15 simulated data. Bmc Proceedings. 1: S34. PMID 18466532 DOI: 10.1186/1753-6561-1-S1-S34 |
0.366 |
|
| 2007 |
de Andrade M, Atkinson EJ, Fridley BL, Goode EL, McDonnell S, Liu-Mares W, Rabe KG, Sun Z, Slager SL. The genetics of gene expression: comparison of linkage scans using two phenotype normalization methods. Bmc Proceedings. S151. PMID 18466496 DOI: 10.1186/1753-6561-1-S1-S151 |
0.334 |
|
| 2007 |
Liu-Mares W, Sun Z, Bamlet WR, Atkinson EJ, Fridley BL, Slager SL, de Andrade M, Goode EL. Analysis of variation in NF-kappaB genes and expression levels of NF-kappaB-regulated molecules. Bmc Proceedings. S126. PMID 18466468 DOI: 10.1186/1753-6561-1-S1-S126 |
0.325 |
|
| 2007 |
Thomas HR, Ezzeldin HH, Guarcello V, Mattison LK, Fridley BL, Diasio RB. Genetic regulation of dihydropyrimidinase and its possible implication in altered uracil catabolism. Pharmacogenetics and Genomics. 17: 973-87. PMID 18075467 DOI: 10.1097/Fpc.0B013E3282F01788 |
0.336 |
|
| 2007 |
Fridley BL, Dixon P. Data augmentation for a Bayesian spatial model involving censored observations Environmetrics. 18: 107-123. DOI: 10.1002/Env.806 |
0.482 |
|
| Show low-probability matches. |